Cargando…
Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across
The recent approval of messenger RNA (mRNA)-based vaccines to combat the SARS-CoV-2 pandemic highlights the potential of both conventional mRNA and self-amplifying mRNA (saRNA) as a flexible immunotherapy platform to treat infectious diseases. Besides the antigen it encodes, mRNA itself has an immun...
Autores principales: | Minnaert, An-Katrien, Vanluchene, Helena, Verbeke, Rein, Lentacker, Ine, De Smedt, Stefaan C., Raemdonck, Koen, Sanders, Niek N., Remaut, Katrien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325057/ https://www.ncbi.nlm.nih.gov/pubmed/34324884 http://dx.doi.org/10.1016/j.addr.2021.113900 |
Ejemplares similares
-
The dawn of mRNA vaccines: The COVID-19 case
por: Verbeke, Rein, et al.
Publicado: (2021) -
Vaccinia Virus Protein B18R: Influence on mRNA Immunogenicity and Translation upon Non-Viral Delivery in Different Ocular Cell Types
por: Minnaert, An-Katrien, et al.
Publicado: (2021) -
A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs
por: Bogaert, Bram, et al.
Publicado: (2022) -
Together is Better: mRNA Co‐Encapsulation in Lipoplexes is Required to Obtain Ratiometric Co‐Delivery and Protein Expression on the Single Cell Level
por: Zhang, Heyang, et al.
Publicado: (2021) -
Theranostic mRNA-loaded Microbubbles in the Lymphatics of Dogs: Implications for Drug Delivery
por: Dewitte, Heleen, et al.
Publicado: (2015)